Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep1042 | Thyroid | ECE2022

Graves’ disease associated with thyroid papillary carcinoma

Masmoudi Mohamed , Regaeig Marwa , Thabet Wadii , Chebil Azer , Hasnaoui Mehdi , Mighri Khalifa

Introduction: Thyroid carcinoma in Graves’ disease is rare (1 to 2%). Papillary carcinoma is the most common histologic type. It is usually discovered incidentally after histologic exam. Our aim is to report a case of Graves’ disease associated with thyroid papillary carcinoma and to describe its therapeutic and prognostic features.Case report: A 51-year-old woman treated with anti-thyroid drugs and β blockers for Graves’ disease. Cer...

ea0081ep1097 | Thyroid | ECE2022

A rare localization of lymph node metastasis from papillary thyroid carcinoma

Masmoudi Mohamed , Thabet Wadii , Regaeig Marwa , Chebil Ezer , Hasnaoui Mehdi , Mighri Khalifa

Introduction: Lymph node (LN) metastases of papillary thyroid carcinoma (PTC) usually happen in the paratracheal and internal jugular chain and are unusual in the parapharyngeal space (PPS). Our aim is to emphasize on the possibility of parapharyngeal metastatic LNs in PTC and to describe the diagnosis methods, treatment options, and impact on the prognosis.Case Report: A 62-year-old woman presented with a dysphagia lasting for 2 years. Examination revea...

ea0081ep1160 | Thyroid | ECE2022

Surgical treatment of Graves’ disease

Masmoudi Mohamed , Regaeig Marwa , Thabet Wadii , Chebil Azer , Hasnaoui Mehdi , Mighri Khalifa

Introduction: Graves’ disease is an autoimmune disease of the thyroid gland, which represents the most common cause of hyperthyroidism, accounting for 50 - 80% of all cases. Three treatment options are available for Graves’ disease: anti-thyroid drugs, radioactive iodine and thyroidectomy. But therapeutic management is still controversial. The aim of our study is to discuss, after a review of the literature, the role of surgery in the treatment of Graves’ diseas...